Freedom to Publish. 10.1 The Company acknowledges the Consultant’s obligation to disseminate new knowledge and research findings. Consistent with the confidentiality provisions, or any other provision, of this Agreement, the Consultant may publish and make oral representations of the results of the Consultant’s work performed pursuant to this Agreement under the terms set forth in this Section 10. 10.2 The Consultant acknowledges that publication or oral disclosure of any Invention or other work prior to filing for patent or copyright protection could result in the complete loss of any commercial value of the Consultant’s research to the Institution, the Company, and/or the Consultant, as the case may be. The Consultant will provide the Company with sufficient disclosure regarding Inventions owned by the Company under Section 8 at least 90 days prior to publication to allow the Company to evaluate such disclosure; Consultant will work with the Institution (and the Company if appropriate) to file patent or copyright applications prior to disclosure or publication, or to modify such publication if such disclosure regarding Inventions owned by the Company under Section 8 would materially affect the business of the Company.
Appears in 3 contracts
Samples: Consulting Agreement (Bayhill Therapeutics, Inc.), Consulting Agreement (Bayhill Therapeutics, Inc.), Consulting Agreement (Bayhill Therapeutics, Inc.)
Freedom to Publish. 10.1 The Company acknowledges the that Consultant’s 's obligation to disseminate new knowledge and research findings. Consistent with Notwithstanding the confidentiality provisions, or any other provision, of this Agreement, the Consultant may publish and make oral representations presentations of the results of the Consultant’s 's work performed pursuant to this Agreement under the terms set forth in this Section 10.
10.2 The Consultant acknowledges that publication or oral disclosure disclose of any Invention or other work prior to filing for patent or copyright protection could result in the complete loss of any commercial value of the Consultant’s 's research to the Institution, the Company, and/or the Consultant, as the case may be. The Consultant will provide the Company with sufficient disclosure regarding Inventions owned by the Company under Section 8 at least 90 days prior to publication to allow the Company to evaluate such disclosure; Consultant will work with the Institution (and the Company if appropriate) to file patent or copyright applications prior to disclosure or publication, or to modify such publication if such disclosure regarding Inventions owned by the Company under Section 8 would materially affect the business of the Company.
Appears in 2 contracts
Samples: Consulting Agreement (Pharmacopeia Drug Discovery Inc), Consulting Agreement (Pharmacopeia Drug Discovery Inc)
Freedom to Publish. 10.1 10.1. The Company acknowledges the Consultant’s 's obligation to disseminate new knowledge and research findings. Consistent with Notwithstanding the confidentiality provisions, or any other provision, of this Agreement, the Consultant may publish and make oral representations presentations of the results of the Consultant’s 's work performed pursuant to this Agreement under the terms set forth in this Section 10.
10.2 10.2. The Consultant acknowledges that publication or oral disclosure of any Invention or other work prior to filing for patent or copyright protection could result in the complete loss of any commercial value of the Consultant’s 's research to the Institution, the Company, and/or the Consultant, as the case may be. The Consultant will provide the Company with sufficient disclosure regarding Inventions owned by the Company under Section 8 at least 90 days prior to publication to allow the Company to evaluate such disclosure; Consultant will work with the Institution (and the Company if appropriate) to file patent or copyright applications prior to disclosure or publication, or to modify such publication if such disclosure regarding Inventions owned by the Company under Section 8 would materially affect the business of the Company.
Appears in 1 contract
Freedom to Publish. 10.1 9.1 The Company acknowledges the Consultant’s 's obligation to disseminate new knowledge and research findings. Consistent with Notwithstanding the confidentiality provisions, or any other provision, of this Agreement, the Consultant may publish and make oral representations presentations of the results of the Consultant’s 's work performed pursuant to this Agreement under the terms set forth in this Section 109.
10.2 9.2 The Consultant acknowledges that publication or oral disclosure of any Invention or other work prior to filing for patent or copyright protection could result in the complete loss of any commercial value of the Consultant’s 's research to the Institution, the Company, Company and/or the Consultant, as the case may be. The Consultant will provide the Company with sufficient disclosure regarding Inventions owned by the Company under Section 8 7 at least 90 days prior to submission for publication to allow the Company to evaluate such disclosure; Consultant will work with the Institution any third party (and the Company if appropriate) to file patent or copyright applications prior to disclosure publication or publicationoral disclosure, or to modify such publication or oral disclosure if such disclosure regarding Inventions owned by the Company under Section 8 7 would materially affect the business of the Company.
Appears in 1 contract
Freedom to Publish. 10.1 The Company acknowledges the Consultant’s 's obligation to disseminate new knowledge and research findings. Consistent with Notwithstanding the confidentiality provisions, or any other provision, of this Agreement, the Consultant may publish and make oral representations presentations of the results of the Consultant’s 's work performed pursuant to this Agreement under the terms set forth in this Section 10.
10.2 The Consultant acknowledges that publication or oral disclosure of any Invention or other work prior to filing for patent or copyright protection could result in the complete loss of any commercial value of the Consultant’s 's research to the Institution, the Company, and/or the Consultant, as the case may be. The Consultant will provide the Company with sufficient disclosure regarding Inventions owned by the Company under Section 8 at least 90 days prior to publication to allow the Company to evaluate such disclosure; Consultant will work with the Institution (and the Company if appropriate) to file patent or copyright applications prior to disclosure or publication, or to modify such publication if such disclosure regarding Inventions owned by the Company under Section 8 would materially affect the business of the Company.
Appears in 1 contract
Samples: Consulting Agreement (Nanosys Inc)